Back to Search Start Over

Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M.

Authors :
Abe H
Takeda N
Isagawa T
Semba H
Nishimura S
Morioka MS
Nakagama Y
Sato T
Soma K
Koyama K
Wake M
Katoh M
Asagiri M
Neugent ML
Kim JW
Stockmann C
Yonezawa T
Inuzuka R
Hirota Y
Maemura K
Yamashita T
Otsu K
Manabe I
Nagai R
Komuro I
Source :
Nature communications [Nat Commun] 2019 Jun 27; Vol. 10 (1), pp. 2824. Date of Electronic Publication: 2019 Jun 27.
Publication Year :
2019

Abstract

The fibrogenic response in tissue-resident fibroblasts is determined by the balance between activation and repression signals from the tissue microenvironment. While the molecular pathways by which transforming growth factor-1 (TGF-β1) activates pro-fibrogenic mechanisms have been extensively studied and are recognized critical during fibrosis development, the factors regulating TGF-β1 signaling are poorly understood. Here we show that macrophage hypoxia signaling suppresses excessive fibrosis in a heart via oncostatin-m (OSM) secretion. During cardiac remodeling, Ly6C <superscript>hi</superscript> monocytes/macrophages accumulate in hypoxic areas through a hypoxia-inducible factor (HIF)-1α dependent manner and suppresses cardiac fibroblast activation. As an underlying molecular mechanism, we identify OSM, part of the interleukin 6 cytokine family, as a HIF-1α target gene, which directly inhibits the TGF-β1 mediated activation of cardiac fibroblasts through extracellular signal-regulated kinase 1/2-dependent phosphorylation of the SMAD linker region. These results demonstrate that macrophage hypoxia signaling regulates fibroblast activation through OSM secretion in vivo.

Details

Language :
English
ISSN :
2041-1723
Volume :
10
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
31249305
Full Text :
https://doi.org/10.1038/s41467-019-10859-w